Grant, award or other acquisition by Skvarka Jan
Zentalis Pharmaceuticals, Inc.
Transaction date
- Shares
- 57,100
- Price per share
- 0.00
People / SEC CIK 0001838042
Career history and related SEC filings
Browse linked events from SEC filings within FilingRelay's coverage.
Allow Google Analytics to measure visits and clicks on SEC source links. You can change your choice at any time.